For now, several LSD1 inhibitors including TCP, ORY-1001, GSK2879552, IMG-7289, INCB059872, and ORY-2001(Vafidemstat) are being tested in clinical trials targeting anti-tumor traits, alone or in combined treatment for cancer therapy (Fang et al., 2019). The gene discussed is KDM1A; the disease is neoplasm.